Haverford Financial Services’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-6,320
Closed -$684K 66
2021
Q1
$684K Sell
6,320
-4,900
-44% -$524K 0.18% 51
2020
Q4
$1.2M Buy
11,220
+2,655
+31% +$255K 0.33% 36
2020
Q3
$750K Buy
+8,565
New +$806K 0.23% 44

Other funds holding ABBV

Haverford Financial Services's ABBV Position: Q2 2021 in Review

Haverford Financial Services sold out of AbbVie (ABBV) in Q2 2021, closing a stake of 6,320 shares — an estimated $684K sold.

Haverford Financial Services first reported a position in ABBV in Q3 2020 and held it in 3 quarters. The position peaked at $1.2M in Q4 2020. 2,677 funds tracked by Wall St. Rank hold ABBV as of Q2 2021.

  • Haverford Financial Services reported no remaining AbbVie position as of Q2 2021 after selling out during the quarter.
  • Haverford Financial Services sold 6,320 AbbVie shares in Q2 2021, an estimated $684K.
  • Haverford Financial Services first reported a position in AbbVie in Q3 2020 and held it in 3 quarters.
  • Haverford Financial Services's AbbVie position peaked at $1.2M in Q4 2020.
  • 2,677 funds tracked by Wall St. Rank held AbbVie as of Q2 2021.

Based on Haverford Financial Services's 13F filing for Q2 2021, filed 16 Aug 2021.